6 citations · 12 across the 4 of their papers we have counts for
Showing 2025Show all
2 papers · 1 filter
q-bio.BM2025★ 3 cited
Drug-like antibodies with low immunogenicity in human panels designed with Latent-X2
Latent Labs Team, Henry Kenlay, Daniella Pretorius +15
Drug discovery has long sought computational systems capable of designing drug-like molecules directly: developable and non-immunogenic from the start. Here we introduce Latent-X2,…
q-bio.BM2025★ 3 cited
Latent-X: An Atom-level Frontier Model for De Novo Protein Binder Design
Latent Labs Team, Alex Bridgland, Jonathan Crabbé +13
Traditional drug discovery relies on rounds of screening millions of candidate molecules with low success rates, making drug discovery time and resource intensive. To overcome this…